pharma news today obesity drugs glp-1 september 2025 Novo Nordisk cuts forecast amid slower sales The future of GLP-1s: Cost,

NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production

Mancini SA, Angelo JL, Peckler Z, Philp FH, Farah KF

GLPs are synthetic analogues of naturally occurring GLP hormones that stimulate GLP-1 receptors

A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice

Typical results vary up to 6 and 8 pounds lost during the first two weeks and up to 2 pounds per week thereafter when the Ideal Protein Weight Loss Protocol is followed properly

While some patients adapt, others face significant quality-of-life impacts, including reduced food intake, dehydration risk, and compromised nutritional status if not monitored by a healthcare provider